Eyenovia (EYEN) announced that Avenue Capital Management has agreed to support a potential restructuring of Eyenovia’s Loan and Security Agreement and has agreed to defer principal and interest payments on its outstanding debt until the end of February 2025. Eyenovia also announced that it is taking additional actions that are intended to reduce the Company’s ongoing personnel-related costs by over 70%. “We are grateful to Avenue Capital for the support they have demonstrated during this challenging time,” stated Michael Rowe, CEO of Eyenovia. “We took immediate steps to restructure our costs and extend our runway to allow us the flexibility to explore a broad range of strategic alternatives.” As previously disclosed, Eyenovia is considering a variety of steps to maximize value to all stakeholders, to reduce expenses and to evaluate its strategic options, which may include a business combination, reverse merger, asset sales or a combination of those alternatives. Further information will be made available once the evaluation of strategic options has been completed.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on EYEN:
- Biotech Alert: Searches spiking for these stocks today
- Eyenovia downgraded to Neutral from Buy at Ladenburg
- Eyenovia downgraded to Neutral from Buy at H.C. Wainwright
- Eyenovia downgraded to Market Perform from Outperform at William Blair
- Eyenovia downgraded to Hold from Buy at Brookline
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
